Wednesday August 19, 2026
Section

Trending

Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press Release

Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

RESEARCH TRIANGLE PARK, N.C., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage

Read Full Story